Angiodynamics (ANGO) Capital Expenditures (2010 - 2026)

Angiodynamics has reported Capital Expenditures for 17 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 2.37% year-over-year to $1.4 million; the trailing twelve-month figure through Feb 2026 stood at $3.1 million (down 29.93% YoY), and the FY2025 full-year result was $4.5 million, up 77.28% from the prior year.
• Capital Expenditures for Q1 2026 stood at $1.4 million, up from $422000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $6.5 million in Q1 2022, with the low at -$4.4 million in Q2 2022.
• Historically, Capital Expenditures has averaged $908823.5 across 5 years, with a median of $1.1 million in 2024.
• Annual changes were most pronounced in 2022 — Capital Expenditures sank 806.29% — and 2025, when it surged 2675.93%.
• Angiodynamics' Capital Expenditures stood at $1.2 million in 2022, then changed by 0.0% to $1.2 million in 2023, then advanced by 13.99% to $1.4 million in 2024, then slumped by 69.53% to $422000.0 in 2025, then jumped by 221.8% to $1.4 million in 2026.
• The last three Capital Expenditures figures came in at $1.4 million (Q1 2026), $422000.0 (Q4 2025), and $731000.0 (Q3 2025), per Business Quant data.